Anti-TPTE2/ TPIP monoclonal antibody

Anti-TPTE2/ TPIP antibody for FACS & in-vivo assay

Target products collectionGo to TPTE2/TPTE2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1864-Ab-1/ GM-Tg-hg-MP1864-Ab-2Anti-Human TPTE2 monoclonal antibodyHuman
GM-Tg-rg-MP1864-Ab-1/ GM-Tg-rg-MP1864-Ab-2Anti-Rat TPTE2 monoclonal antibodyRat
GM-Tg-mg-MP1864-Ab-1/ GM-Tg-mg-MP1864-Ab-2Anti-Mouse TPTE2 monoclonal antibodyMouse
GM-Tg-cynog-MP1864-Ab-1/ GM-Tg-cynog-MP1864-Ab-2Anti-Cynomolgus/ Rhesus macaque TPTE2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1864-Ab-1/ GM-Tg-felg-MP1864-Ab-2Anti-Feline TPTE2 monoclonal antibodyFeline
GM-Tg-cang-MP1864-Ab-1/ GM-Tg-cang-MP1864-Ab-2Anti-Canine TPTE2 monoclonal antibodyCanine
GM-Tg-bovg-MP1864-Ab-1/ GM-Tg-bovg-MP1864-Ab-2Anti-Bovine TPTE2 monoclonal antibodyBovine
GM-Tg-equg-MP1864-Ab-1/ GM-Tg-equg-MP1864-Ab-2Anti-Equine TPTE2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1864-Ab-1/ GM-Tg-hg-MP1864-Ab-2; GM-Tg-rg-MP1864-Ab-1/ GM-Tg-rg-MP1864-Ab-2;
GM-Tg-mg-MP1864-Ab-1/ GM-Tg-mg-MP1864-Ab-2; GM-Tg-cynog-MP1864-Ab-1/ GM-Tg-cynog-MP1864-Ab-2;
GM-Tg-felg-MP1864-Ab-1/ GM-Tg-felg-MP1864-Ab-2; GM-Tg-cang-MP1864-Ab-1/ GM-Tg-cang-MP1864-Ab-2;
GM-Tg-bovg-MP1864-Ab-1/ GM-Tg-bovg-MP1864-Ab-2; GM-Tg-equg-MP1864-Ab-1/ GM-Tg-equg-MP1864-Ab-2
Products NameAnti-TPTE2 monoclonal antibody
Formatmab
Target NameTPTE2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TPTE2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TPTE2/ TPIP VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1864
    Target NameTPTE2
    Gene ID93492,704870
    Gene Symbol and SynonymsTPIP,TPTE2
    Uniprot AccessionQ6XPS3
    Uniprot Entry NameTPTE2_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000132958
    Target ClassificationN/A

    The target: TPTE2, gene name: TPTE2, also named as TPIP. TPIP is a member of a large class of membrane-associated phosphatases with substrate specificity for the 3-position phosphate of inositol phospholipids.[supplied by OMIM, Jul 2002].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.